Jessica Stanfill
Family Health · Lexington, TNNPI 1134505514
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 175 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Novo Nordisk at 28.5% of the total.
Across 175 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$794
- AbbVie$461
- AstraZeneca$337
- Lilly USA, LLC$212
- Amgen$188
- Pfizer$169
- plus $627 from 14 others
What the payments were for
- Food & beverage$2,787100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 50 | $794 |
| AbbVie | 37 | $461 |
| AstraZeneca | 21 | $337 |
| Lilly USA, LLC | 14 | $212 |
| Amgen | 10 | $188 |
| Pfizer | 9 | $169 |
| Boehringer Ingelheim | 8 | $147 |
| GSK | 6 | $119 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Johnson & Johnson | 4 | $72 |
| Bayer | 3 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Novartis | 1 | $13 |
| Merck | 1 | $12 |
How this compares
Too few family health providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 102 | $144,406 |
| TrulicityDulaglutide | 84 | $93,117 |
| FarxigaDapagliflozin Propanediol | 82 | $82,242 |
| EliquisApixaban | 62 | $53,877 |
| JardianceEmpagliflozin | 35 | $43,490 |
| JanuviaSitagliptin Phosphate | 46 | $41,990 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $40,575 |
| LinzessLinaclotide | 26 | $24,025 |
| XareltoRivaroxaban | 17 | $16,470 |
| TradjentaLinagliptin | 18 | $15,792 |
| Xigduo XrDapaglifloz Propaned/Metformin | 19 | $11,646 |
| MounjaroTirzepatide | 11 | $11,058 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $5,433 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $5,103 |
| Febuxostat | 13 | $4,725 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $794 | $144,406102 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $212 | $104,17595 claims |
| AstraZenecaFarxiga, Symbicort | $337 | $87,345104 claims |
| Boehringer IngelheimJardiance, Tradjenta | $147 | $59,28253 claims |
| PfizerEliquis | $169 | $53,87762 claims |
| MerckJanuvia | $12 | $41,99046 claims |
| GSKTrelegy Ellipta | $119 | $40,57537 claims |
| AbbVieLinzess | $461 | $24,02526 claims |
| Johnson & JohnsonXarelto | $72 | $16,47017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few family health providers in Tennesseeon file to place this against a meaningful peer group, so we don't.
Other family health in Lexington
- Lindsay FrazierKnoxville$140K
- Erin DickersonGermantown$8K
- Evelyn WrightLawrenceburg$2K
- Honiko AbramsChattanooga$1K
- Carla FrankHixson$457
- Donna WinninghamCookeville$209
- Donna HarrisGermantown$101
- Brooke TorbettMadisonville$44
- Carol CampbellNashville$23
- Mary JordanJasper$21
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.